Normal E. Bolus elected 2018-2019 president of SNMMI-TS

Michael Walter | | Radiology Business | Nuclear Medicine
Norman E. Bolus

Norman E. Bolus, MSPH, MPH, CNMT, was elected 2018-2019 president of the Society of Nuclear Medicine and Molecular Imaging Technologist Section (SNMMI-TS) at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2018 Annual Meeting in Philadelphia.

Bolus has worked as a nuclear medicine technologist for almost 29 years. He currently serves as program director and assistant professor at the University of Alabama at Birmingham (UAB) Master of Science in Nuclear Medicine Technology Program and interim program director of the school’s Master of Science in Health Physics Program.

“As president of the SNMMI-TS, I will focus on increasing membership and supporting advocacy efforts, including scope of practice issues within the profession,” Bolus said in a prepared statement. “I will also explore opportunities to integrate progress on the goals of the society’s Quality Initiative and Value Initiative, as quality and value go hand-in-hand. In addition, I will continue working with the SNMMI-TS Committee Chairs to achieve the objectives of the SNMMI-TS strategic plan.”

Bolus also served a six-year term as editor-in-chief of the Journal of Nuclear Medicine Technology from January 2012 to December 2017 and has been president of the Alabama Society of Nuclear Medicine twice.

In other SNMMI news, Mark H. Crosthwaite, MEd, CNMT, PET, was elected as the 2018-19 president-elect of SNMMI-TS during the SNMMI 2018 Annual Meeting.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Policy reforms in Washington that will impact nuclear imaging
U.S. moves closer to establishing domestic supply of Mo-99 for nuclear imaging
Siemens Healthineers finalizes $223M purchase of Novartis’ imaging unit
GE HealthCare acquires full stake in radiopharma firm that generated $183M last year
Radiologists say hidden fat can predict Alzheimer’s 20 years before symptoms arise
Radiopharmaceutical firm Telix investing up to $171M to acquire portfolio of imaging agents

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.